Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Paris - Delayed Quote EUR

GenSight Biologics S.A. (SIGHT.PA)

Compare
0.2230
-0.0100
(-4.29%)
At close: April 9 at 5:35:26 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,267
1,267
2,582
5,276
4,394
Operating Expense
30,963
30,963
30,417
33,401
29,329
Operating Income
-29,696
-29,696
-27,835
-28,125
-24,935
Net Non Operating Interest Income Expense
-3,153
-3,153
-2,972
-2,166
-1,628
Pretax Income
-26,221
-26,221
-27,619
-28,615
-34,015
Tax Provision
--
--
5
2
2
Net Income Common Stockholders
-26,220
-26,220
-27,625
-28,617
-34,015
Diluted NI Available to Com Stockholders
-26,220
-26,220
-27,625
-28,617
-34,015
Basic EPS
-0.54
-0.54
-0.60
-0.63
-0.97
Diluted EPS
-0.54
-0.54
-0.60
-0.63
-0.97
Basic Average Shares
48,316.3390
48,316.3390
46,330.3030
45,150.5920
35,126.6880
Diluted Average Shares
48,316.3390
48,316.3390
46,330.3030
45,150.5920
35,126.6880
Total Operating Income as Reported
-29,696
-29,696
-27,835
-28,126
-24,934
Rent Expense Supplemental
2
--
--
--
--
Total Expenses
30,963
30,963
30,417
33,401
29,329
Net Income from Continuing & Discontinued Operation
-26,220
-26,220
-27,625
-28,617
-34,015
Normalized Income
-33,061
-33,061
-30,161
-29,926
-26,656
Interest Income
--
--
--
--
89
Interest Expense
3,152
3,152
2,650
2,166
1,717
Net Interest Income
-3,153
-3,153
-2,972
-2,166
-1,628
EBIT
-23,069
-23,069
-24,969
-26,449
-32,298
EBITDA
-20,890
-20,890
-23,908
-25,521
-31,372
Reconciled Depreciation
2,179
2,179
1,061
928
926
Net Income from Continuing Operation Net Minority Interest
-26,220
-26,220
-27,625
-28,617
-34,015
Total Unusual Items Excluding Goodwill
6,841
6,841
2,536
1,309
-7,359
Total Unusual Items
6,841
6,841
2,536
1,309
-7,359
Normalized EBITDA
-27,731
-27,731
-26,444
-26,830
-24,013
12/31/2020 - 7/13/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABVX.PA ABIVAX Société Anonyme
4.5600
-11.11%
 
OSE.PA OSE Immunotherapeutics SA
5.15
-7.62%
 
POXEL.PA Poxel S.A.
0.5270
+86.22%
 
ALBPS.PA Biophytis S.A.
0.1850
-2.58%
 
ALNEV.PA Neovacs S.A.
0.0369
0.00%
 
PHXM.PA PHAXIAM Therapeutics S.A.
0.6840
+2.70%
 
IVA.PA Inventiva S.A.
2.6750
-2.73%
 
ADOC.PA Adocia SA
3.3600
-6.28%
 
DBV.PA DBV Technologies S.A.
1.2000
-6.10%
 
ALTHX.PA Theranexus Société Anonyme
0.4058
-0.95%